domain | expressionedits.com |
summary | Expression Edits, a company specializing in gene therapy applications and leveraging an innovative Genetic Syntax Engine for optimizing potency without altering core designs, is seeking collaborators as of March 2025 when Dr. Amrik Basran joined them with the position Chief Scientific Officer; they had previously collaborated on developing enhanced therapies by partnering Boehringer Ingelheim (February 2025), appointed new board chair Paul Bolno in December 2024 and raised $13 million for advancing intronization technology to improve protein expression using AI. |
title | ExpressionEdits |
description | Redefining the status quo of protein expression |
keywords | gene, protein, designs, introns, syntax, senior, founder, engine, therapy, design, proteins, using, like, expression, technology, names, team |
upstreams |
|
downstreams |
|
nslookup | A 52.223.52.2, A 35.71.142.77 |
created | 2025-05-31 |
updated | 2025-05-31 |
summarized | 2025-06-05 |
|
|